Post-Operative Pain Control Following Shoulder Surgery

NCT04622839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2023-02-16

No results posted yet for this study

Summary

This study will evaluate overall opioid and non-narcotic analgesic use following surgical treatment for shoulder pathology, and recommend evidence based guidelines for standardized postoperative pain management.

Conditions

  • Shoulder Pain

Interventions

OTHER

Tylenol and NSAIDS (Ibuprofen, diclofenac)

This study will assess an aspect of perioperative care relating to pain control. Subjects will not be aware of which aspect is randomized, but will be given a list of possible aspects which will include the intervention (listed below): * Agents used in nerve block (lidocaine vs ropivacaine) * Location of injection for analgesic * Use of over-the-counter pain management (including but not limited to acetaminophen, ibuprofen, naproxen, etc.) * Type of initial opioid prescribed (including but not limited to oxycodone, tramadol, hydrocodone, etc.) * Number of pills in the initial opioid prescription * Instructions for sling wear (duration of use or type of sling) * Ice usage (duration of use and frequency of use) Blinding the participant to the randomized aspect of this study will help prevent bias in patient responses for outcome scores and medication usage.

Sponsors & Collaborators

Principal Investigators

  • Umasuthan Srikumaran, M.D. · Johns Hopkins Orthopedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04622839 on ClinicalTrials.gov